Cytek Biosciences (CTKB) EBITDA Margin Growth (5y) (2025 - 2026)
Powered by 
Analysis
Cytek Biosciences (CTKB) EBITDA Margin Growth (5y) (2025 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 224.92 Bn | 220.85 Bn | 8.34 Bn |
| 2 | Danaher | 144.72 Bn | 140.37 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 41.07 Bn | 39.31 Bn | 1.04 Bn |
| 4 | Illumina | 31.27 Bn | 30.10 Bn | 770.00 Mn |
| 5 | Revvity | 13.85 Bn | 12.82 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.14 Bn | 8.52 Bn | 345.80 Mn |
| 8 | Repligen | 9.32 Bn | 8.31 Bn | 110.04 Mn |
| 9 | 10x Genomics | 8.65 Bn | 8.10 Bn | 112.50 Mn |
| 10 | Cytek Biosciences | 611.05 Mn | 537.21 Mn | 28.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3,621.00 |
| Mar 31, 2026 | -4,650.00 |
| Dec 31, 2025 | -3,472.00 |
| Sep 30, 2025 | -4,432.00 |
| Jun 30, 2025 | -2,216.00 |